# Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing

> **NCT05402254** · NA · COMPLETED · sponsor: **Natalia Rodriguez Galan** · enrollment: 395 (actual)

## Conditions studied

- Adverse Drug Event

## Interventions

- **OTHER:** Pharmacovigilance Program

## Key facts

- **NCT ID:** NCT05402254
- **Lead sponsor:** Natalia Rodriguez Galan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05402254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05402254, "Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05402254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*